Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 2/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.39 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31494541 | 1.00 | TRPV4 (0.60) | TRPV4MEN1KMT2AALOX15MAPK1 | |
| SCHEMBL5348639 | 0.87 | TRPV4 (0.57) | TRPV4MEN1KMT2AALOX15MAPK1 | |
| SCHEMBL1036692 | 0.87 | ALPL (0.52) | TRPV4MEN1KMT2AALOX15MAPK1 | |
| SCHEMBL30440381 | 0.86 | TRPV4 (0.64) | TRPV4MEN1KMT2AALPLGAA | |
| SCHEMBL2747879 | 0.86 | TRPV4 (0.64) | TRPV4MEN1KMT2AALPLGAA | |
| SCHEMBL25318109 | 0.83 | KMT2A (0.43) | TRPV4MEN1KMT2AALOX15MAPK1 | |
| SCHEMBL8764653 | 0.83 | TRPV4 (0.57) | TRPV4MAPK1SCN9ACYP2C19MAPT | |
| SCHEMBL25362679 | 0.79 | MCL1 (0.51) | TRPV4MEN1KMT2AMAPK1KIF11 | |
| SCHEMBL4676395 | 0.78 | TRPV4 (0.54) | TRPV4GAAMAPTKDM4EALDH1A1 | |
| SCHEMBL2502219 | 0.78 | TRPV4 (0.57) | TRPV4ALPLKIF11GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448109-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | Aurigene Oncology Limited (IN) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114710-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114710-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2023-06-22 | — | — | WO | disclosed |
| EP-1290001-B1 | PROCESS FOR THE SELECTIVE DEPROTONATION AND FUNCTIONALIZATION OF 3-SUBSTITUTED BENZOTRIFLUORIDES | DOW AGROSCIENCES LLC (US) | 2004-11-03 | — | — | EP | disclosed |
| EP-1290001-A1 | PROCESS FOR THE SELECTIVE DEPROTONATION AND FUNCTIONALIZATION OF 3-SUBSTITUTED BENZOTRIFLUORIDES | Dow AgroSciences LLC (US) | 2003-03-12 | — | — | EP | disclosed |
| US-6462240-B2 | FROMING 2-LITHIOBENZOTRIFLORIDE FROM BENZOTRIFLUORIDE AND ALKYLLITHIUM | DOW AGROSCIENCES LLC | 2002-10-08 | — | — | US | disclosed |
| US-20020010375-A1 | Process for the selective deprotonation and functionalization of 3-substituted benzotrifluorides | CORTEVA AGRISCIENCE LLC | 2002-01-24 | — | — | US | disclosed |
| WO-2001096348-A1 | PROCESS FOR THE SELECTIVE DEPROTONATION AND FUNCTIONALIZATION OF 3-SUBSTITUTED BENZOTRIFLUORIDES | DOW AGROSCIENCES LLC (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-0511826-B1 | Phosphosulfonate herbicides | ROHM & HAAS (US) | 1997-07-16 | — | — | EP | disclosed |
| US-5500405-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| US-5272128-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0511826-A2 | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1992-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010375-A1 | Process for the selective deprotonation and functionalization of 3-substituted benzotrifluorides | BPTF, FGFR2, FGFR4 | TRPV4 209/4885MEN1 2913/4885KMT2A 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.